These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 17937061

  • 1. Growth and pubertal characteristics in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Trinh L, Nimkarn S, New MI, Lin-Su K.
    J Pediatr Endocrinol Metab; 2007 Aug; 20(8):883-91. PubMed ID: 17937061
    [Abstract] [Full Text] [Related]

  • 2. Early growth, pubertal development, body mass index and final height of patients with congenital adrenal hyperplasia: factors influencing the outcome.
    Manoli I, Kanaka-Gantenbein Ch, Voutetakis A, Maniati-Christidi M, Dacou-Voutetakis C.
    Clin Endocrinol (Oxf); 2002 Nov; 57(5):669-76. PubMed ID: 12390343
    [Abstract] [Full Text] [Related]

  • 3. Reduced final height outcome in congenital adrenal hyperplasia under prednisone treatment: deceleration of growth velocity during puberty.
    Bonfig W, Bechtold S, Schmidt H, Knorr D, Schwarz HP.
    J Clin Endocrinol Metab; 2007 May; 92(5):1635-9. PubMed ID: 17299071
    [Abstract] [Full Text] [Related]

  • 4. Hydrocortisone dosing during puberty in patients with classical congenital adrenal hyperplasia: an evidence-based recommendation.
    Bonfig W, Pozza SB, Schmidt H, Pagel P, Knorr D, Schwarz HP.
    J Clin Endocrinol Metab; 2009 Oct; 94(10):3882-8. PubMed ID: 19622620
    [Abstract] [Full Text] [Related]

  • 5. Growth patterns and final height in congenital adrenal hyperplasia due to classical 21-hydroxylase deficiency. Results of a multicenter study.
    Hargitai G, Sólyom J, Battelino T, Lebl J, Pribilincová Z, Hauspie R, Kovács J, Waldhauser F, Frisch H, MEWPE-CAH Study Group.
    Horm Res; 2001 Oct; 55(4):161-71. PubMed ID: 11598369
    [Abstract] [Full Text] [Related]

  • 6. Growth curves for congenital adrenal hyperplasia from a national retrospective cohort.
    Bretones P, Riche B, Pichot E, David M, Roy P, Tardy V, Kassai B, Gaillard S, Bernoux D, Morel Y, Chatelain P, Nicolino M, Cornu C, French Collaborative CAH Growth Study Group.
    J Pediatr Endocrinol Metab; 2016 Dec 01; 29(12):1379-1388. PubMed ID: 27852974
    [Abstract] [Full Text] [Related]

  • 7. Puberty and fertility in congenital adrenal hyperplasia.
    Otten BJ, Stikkelbroeck MML, Claahsen-van der Grinten HL, Hermus ARMM.
    Endocr Dev; 2005 Dec 01; 8():54-66. PubMed ID: 15722617
    [Abstract] [Full Text] [Related]

  • 8. Long-term follow-up of children with classic congenital adrenal hyperplasia: suggestions for age dependent treatment in childhood and puberty.
    Pijnenburg-Kleizen KJ, Thomas CMG, Otten BJ, Roeleveld N, Claahsen-van der Grinten HL.
    J Pediatr Endocrinol Metab; 2019 Oct 25; 32(10):1055-1063. PubMed ID: 31573958
    [Abstract] [Full Text] [Related]

  • 9. The relation of peripubertal and pubertal growth to final adult height in children with classic congenital adrenal hyperplasia.
    Bomberg EM, Addo OY, Kyllo J, Gonzalez-Bolanos MT, Ltief AM, Pittock S, Himes JH, Miller BS, Sarafoglou K.
    J Pediatr; 2015 Mar 25; 166(3):743-50. PubMed ID: 25557963
    [Abstract] [Full Text] [Related]

  • 10. [Congenital adrenal hyperplasia due to 21-hydroxylase deficiency: final height in 27 patients with the classical form].
    Lemos-Marini SH, Guerra-Júnior G, Morcillo AM, Baptista MT, Silva LO, Maciel-Guerra AT.
    Arq Bras Endocrinol Metabol; 2005 Dec 25; 49(6):902-7. PubMed ID: 16544012
    [Abstract] [Full Text] [Related]

  • 11. Longitudinal analysis of growth and puberty in 21-hydroxylase deficiency patients.
    Van der Kamp HJ, Otten BJ, Buitenweg N, De Muinck Keizer-Schrama SM, Oostdijk W, Jansen M, Delemarre-de Waal HA, Vulsma T, Wit JM.
    Arch Dis Child; 2002 Aug 25; 87(2):139-44. PubMed ID: 12138066
    [Abstract] [Full Text] [Related]

  • 12. Near-final height in 82 Chinese patients with congenital adrenal hyperplasia due to classic 21-hydroxylase deficiency: a single-center study from China.
    Juan L, Huamei M, Zhe S, Yanhong L, Hongshan C, Qiuli C, Jun Z, Song G, Minlian D.
    J Pediatr Endocrinol Metab; 2016 Jul 01; 29(7):841-8. PubMed ID: 27054598
    [Abstract] [Full Text] [Related]

  • 13. Congenital adrenal hyperplasia: lessons from a multinational study.
    Frisch H, Waldhauser F, Lebl J, Solyom J, Hargitai G, Kovacs J, Pribilincova Z, Krzisnik C, Battelino T, MEWPE-CAH Study Group.
    Horm Res; 2002 Jul 01; 57 Suppl 2():95-101. PubMed ID: 12065936
    [Abstract] [Full Text] [Related]

  • 14. Non-classical 21-hydroxylase deficiency in infancy and childhood: the effect of time of initiation of therapy on puberty and final height.
    Weintrob N, Dickerman Z, Sprecher E, Galatzer A, Pertzelan A.
    Eur J Endocrinol; 1997 Feb 01; 136(2):188-95. PubMed ID: 9116914
    [Abstract] [Full Text] [Related]

  • 15. HYDROCORTISONE THERAPY AND GROWTH TRAJECTORY IN CHILDREN WITH CLASSICAL CONGENITAL ADRENAL HYPERPLASIA.
    Bizzarri C, Improda N, Maggioli C, Capalbo D, Roma S, Porzio O, Salerno M, Cappa M.
    Endocr Pract; 2017 May 01; 23(5):546-556. PubMed ID: 28225306
    [Abstract] [Full Text] [Related]

  • 16. Long-term Consequences of Congenital Adrenal Hyperplasia due to Classic 21-hydroxylase Deficiency in Adolescents and Adults.
    Kim JH, Choi JH, Kang E, Kim YM, Lee BH, Yoo HW.
    Exp Clin Endocrinol Diabetes; 2017 Mar 01; 125(3):196-201. PubMed ID: 28073127
    [Abstract] [Full Text] [Related]

  • 17. Height, bone mineral density and bone markers in congenital adrenal hyperplasia.
    Paganini C, Radetti G, Livieri C, Braga V, Migliavacca D, Adami S.
    Horm Res; 2000 Mar 01; 54(4):164-8. PubMed ID: 11416232
    [Abstract] [Full Text] [Related]

  • 18. Indicators of adult height outcome in classical 21-hydroxylase deficiency congenital adrenal hyperplasia.
    Muirhead S, Sellers EA, Guyda H, Canadian Pediatric Endocrine Group.
    J Pediatr; 2002 Aug 01; 141(2):247-52. PubMed ID: 12183722
    [Abstract] [Full Text] [Related]

  • 19. Overestimation of final height prediction in patients with classical congenital adrenal hyperplasia using the Bayley and Pinneau method.
    Bonfig W, Schwarz HP.
    J Pediatr Endocrinol Metab; 2012 Aug 01; 25(7-8):645-9. PubMed ID: 23155688
    [Abstract] [Full Text] [Related]

  • 20. Congenital adrenal hyperplasia clinical characteristics and genotype in newborn, childhood and adolescence.
    Pasqualini T, Alonso G, Tomasini R, Galich AM, Buzzalino N, Fernandez C, Minutolo C, Alba L, Dain L.
    Medicina (B Aires); 2007 Aug 01; 67(3):253-61. PubMed ID: 17628913
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.